Revinty Ellipta 92 micrograms/22 micrograms inhalation powder clinical trials

Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE

This study looks at how well people with asthma use their medication (Mepolizumab) and how much it helps control their symptoms over six months. It compares different ways of giving the medication, looking at patient diaries and pharmacy records.